http://eol.org/pages/1078536/names
Bacteria appear to be placed under Insecta in EOL’s taxonomy http://eol.org/pages/40008429/overview Rather puzzling! Any ideas why?
Archive for the '–' Category
Bacteria?
February 20, 2016Customer Letter – Apple
February 19, 2016Biologists urged to hug a preprint : Nature News & Comment
February 18, 2016White label: the growth of bioRxiv | quantixed
February 18, 2016Stopping the big burp | The Economist
February 15, 2016Stopping the big burp
http://www.economist.com/news/science-and-technology/21688374-researchers-new-zealand-are-trying-prevent-livestock-belching #Methane from livestock is a major greenhouse gas, perhaps reducible with genetic engineering
Wild Tomatoes Repel Whiteflies, Study Finds – The New York Times
February 15, 2016NOT-OD-16-011: Implementing Rigor and Transparency in NIH & AHRQ Research Grant Applications
February 14, 2016New grant format w/ prelim. results under significance v. approach as nowhttp://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-011.html @NIH notice is cryptic. People’s thoughts?
+
need to use strength & weakness for each citation.
see also:
http://www.grantcentral.com/wp-content/uploads/2015/12/Supplement-Changes-in-Approach-Subsection.pdf http://grants.nih.gov/grants/forms_updates_faq.htm#2426
http://grants.nih.gov/grants/funding/424/index.htm
QT:{{”
One of the changes to this Chapter pertains to the format for the Approach subsection, which is reproduced, above. “Justification and Feasibility” and its two subdivisions have been lined out because, with the new approach that we recommend, they are no longer part of the Approach subsection. (We have moved them to the Significance subsection, Chapter 9). Without those components, the formatting for each aim “collapses” to include the Introductory Paragraph, Research Design, Expected Outcomes and Potential Problems & Alternative Strategies.
“}}
&
QT:{{”
Updates to Research Strategy Guidance
By November 25, 2015 application guide instructions will be updated to include the following additional guidance for the Significance and Approach sections of the Research Strategy, in addition to the existing instructions.
Significance
Describe the scientific premise for the proposed project, including consideration of the strengths and weaknesses of published research or preliminary data crucial to the support of your application. Approach
Describe the experimental design and methods proposed and how they will achieve robust and unbiased results.
“}}
Do You Know What the 10 Most Expensive Medicare Part B Drugs Are?
February 13, 2016http://www.medicarearticles.com/do-you-know-what-the-10-most-expensive-medicare-part-b-drugs-are
QT:{{”
5. Erbitux
Treats: cancer
Cost: $25,898
4. Primacor, Primacor in Dextrose
Treats: acute decompensated heart failure
Cost: $62,790
3. Ventavis
Treats: pulmonary arterial hypertension
Cost: $84,205
2. Remodulin
Treats: pulmonary arterial hypertension
Cost: $130,772
1. Factor viii Recombinant (various)
Treats: hemophilia A
Cost: $216,833
“}}
contains broken link to GAO report –
http://www.medicarenewsgroup.com/news/medicare-faqs/individual-faq?faqId=48ec6c39-e49a-4bb9-a892-19a6abac8237
